Keywords: helsinn, taiho, sign, deal, palonosetron, japan, acquired
Helsinn and Taiho sign deal for palonosetron
Article | 09 February 2004
Japan's Taiho has acquired the Japanese rights to palonosetron from Helsinn Healthcare SA of Switzerland. After conducting the required clinical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
